Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Bioceres Crop Solutions Corp (NASDAQ: BIOX) closed at $1.4 up 0.72% from its previous closing price of $1.39. In other words, the price has increased by $0.72 from its previous closing price. On the day, 1.1 million shares were traded. BIOX stock price reached its highest trading level at $1.4255 during the session, while it also had its lowest trading level at $1.35.
Ratios:
For a deeper understanding of Bioceres Crop Solutions Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.45. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 0.30.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOX now has a Market Capitalization of 88870336 and an Enterprise Value of 360374144. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28 while its Price-to-Book (P/B) ratio in mrq is 0.34. Its current Enterprise Value per Revenue stands at 1.133 whereas that against EBITDA is 30.519.
Stock Price History:
The Beta on a monthly basis for BIOX is 0.48, which has changed by -0.77883095 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, BIOX has reached a high of $7.44, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -16.40%, while the 200-Day Moving Average is calculated to be -56.69%.
Shares Statistics:
For the past three months, BIOX has traded an average of 812.83K shares per day and 517490 over the past ten days. A total of 61.31M shares are outstanding, with a floating share count of 45.44M. Insiders hold about 28.14% of the company’s shares, while institutions hold 39.70% stake in the company. Shares short for BIOX as of 1764288000 were 1097879 with a Short Ratio of 1.35, compared to 1761868800 on 926526. Therefore, it implies a Short% of Shares Outstanding of 1097879 and a Short% of Float of 2.96.
Earnings Estimates
. The current rating of Bioceres Crop Solutions Corp (BIOX) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.05 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.16 and -$0.42 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is $0.05, with 1.0 analysts recommending between $0.05 and $0.05.
Revenue Estimates
A total of 3 analysts believe the company’s revenue will be $107M this quarter.It ranges from a high estimate of $113.1M to a low estimate of $96M. As of. The current estimate, Bioceres Crop Solutions Corp’s year-ago sales were $106.8MFor the next quarter, 3 analysts are estimating revenue of $60.27M. There is a high estimate of $63.5M for the next quarter, whereas the lowest estimate is $54.5M.
A total of 2 analysts have provided revenue estimates for BIOX’s current fiscal year. The highest revenue estimate was $334.4M, while the lowest revenue estimate was $307.1M, resulting in an average revenue estimate of $320.75M. In the same quarter a year ago, actual revenue was $333.3MBased on 1 analysts’ estimates, the company’s revenue will be $378.7M in the next fiscal year. The high estimate is $378.7M and the low estimate is $378.7M.
